Abstract
The establishment of protocols to differentiate kidney organoids from human pluripotent stem cells provides potential applications of kidney organoids in regenerative medicine. Modeling of renal diseases, drug screening, nephrotoxicity testing of compounds, and regenerative therapy are attractive applications. Although much progress still remains to be made in the development of kidney organoids, recent advances in clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated system 9 (Cas9) genome editing and three-dimensional bioprinting technologies have contributed to the application of kidney organoids in clinical fields. In this section, we review recent advances in the applications of kidney organoids to kidney disease modelling, drug screening, nephrotoxicity testing, and regenerative therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 649-659 |
| Number of pages | 11 |
| Journal | Korean Journal of Internal Medicine |
| Volume | 33 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2018 |
Bibliographical note
Publisher Copyright:© 2018 The Korean Association of Internal Medicine.
Keywords
- Bioprinting
- Clustered regularly interspaced short palindromic repeats
- Kidney
- Organoids
- Transplantation
